Inventor · Pottstown, PA, US

Linda Snyder

33Patents
5h-index
32Co-inventors
69Inventor score

Filing activity: May 6, 1996 → Sep 13, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7163681B2 Anti-integrin antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 101 Expired
US7550142B2 Anti-integrin antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 60 Active
US8071729B2 Anti-integrin antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 52 Active
US5851804A Chimeric kanamycin resistance gene Chemistry; Metallurgy 13 Expired
US11207311B2 Method of treating prostate cancer Human Necessities 5 Active
US10273301B2 Anti-vista antibodies and fragments Chemistry; Metallurgy 4 Active
US8071333B2 Anti-integrin antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 4 Active
US11014987B2 Anti-vista antibodies and fragments, uses thereof, and methods of identifying same Chemistry; Metallurgy 3 Active
US7288390B2 Anti-dual integrin antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 3 Expired
US11009509B2 Anti-VISTA antibodies and fragments Physics 2 Active
US10899836B2 Method of identifying anti-VISTA antibodies Physics 2 Active
US10730950B2 GITR antibodies, methods, and uses Chemistry; Metallurgy 1 Active
US8663980B2 Vectors, host cells, and methods of production and uses Chemistry; Metallurgy 1 Active
US7736650B2 Anti-IL-12 antibody based vectors, host cells, and methods of production and uses Chemistry; Metallurgy 0 Active
US8980626B2 Vectors, host cells, and methods of production and uses Chemistry; Metallurgy 0 Active
US12383543B2 Methods of treating prostate cancer Human Necessities 0 Active
US11992486B2 Methods of treating prostate cancer Human Necessities 0 Active
US7342107B2 Cynomolgus prostate specific antigen Human Necessities 0 Expired
US11649283B2 Anti-human vista antibodies and use thereof Emerging Cross-Sectional Technologies 0 Active
US11986470B2 Methods of treating prostate cancer Human Necessities 0 Active
US11525000B2 Anti-human VISTA antibodies and use thereof Emerging Cross-Sectional Technologies 0 Active
US12139532B2 Anti-human vista antibodies and use thereof Emerging Cross-Sectional Technologies 0 Active
US9206248B2 Vectors, host cells, and methods of production and uses Chemistry; Metallurgy 0 Active
US7666993B2 Cynomolgus prostate specific antigen Human Necessities 0 Active
US8138315B2 Anti-alpha V immunoliposome compositions, methods and uses Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.